Stock FARN FARON PHARMACEUTICALS OY
Add to a list
To use this feature you must be a member
Log inSign up

Analyst Reco. Faron Pharmaceuticals Oy

Equities

FARN

FI4000153309

Delayed London S.E.
Other stock markets
 03:07:16 2024-05-17 am EDT 		5-day change 1st Jan Change
252.8 GBX +1.12% Intraday chart for Faron Pharmaceuticals Oy +28.00% -17.11%
May. 03 Kelso raises stake in NCC; Transense joins project AN
Apr. 30 Faron Pharmaceuticals Ltd. Announces Appointment of Dr. Juho Jalkanen as Director CI

Analyst Reco.

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Faron Pharmaceuticals Reports 100% Response Rate in Phase 1 Trial of Myeloid Leukemia Combo Drug
MT
Faron Pharmaceuticals' Bexmarilimab shows 50% remission rate
AN
Faron Halts Investigational COVID-19 Therapy Trial Due to Low Infection, Hospitalization Rates
MT
Faron Closes HIBISCUS Trial Due to Low COVID-19 Infection and Hospitalization Rates in the US and Reverts Resources to the Development of Bexmarilimab
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. FARN Stock
  4. News Faron Pharmaceuticals Oy
  5. Analyst Reco.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW